EXXUA is now available through Aytu RxConnect® pharmacies to ensure optimal access and availability EXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

WASHINGTON, D.C. (WRIC) — Virginians who take morphine to manage pain are asked to check their bottles after a voluntary recall. Bryant Ranch Prepack, Inc. is voluntarily recalling one lot of 30mg ...

AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) announces the launch of ...

Attention Deficit Hyperactivity Disorder (ADHD) is a chronic neurodevelopmental disorder leading to impairments in learning and behaviour. ADHD affects approx. 3-5% of adults and 5-9% of children and ...

Auvelity (dextromethorphan/bupropion) is a prescription drug that’s used to treat depression. The drug comes as an extended-release tablet. It’s usually taken ...

Mestinon (pyridostigmine bromide) is a brand-name drug that’s prescribed for myasthenia gravis. Mestinon comes as an oral tablet, extended-release oral tablet, and oral solution. The dosage can vary ...

Mordor Intelligence has published a new report on gabapentin market offering a comprehensive analysis of trends, growth drivers, and future projections.

If you have severe, ongoing pain, your doctor may prescribe hydrocodone for you. It’s a strong pain reliever used to help manage extreme pain in adults due to conditions such as cancer or serious ...

PacificNorthwest Naturals was hit with a false advertising class action Tuesday in New York Eastern District Court over its 'Genius Brand' extended-release caffeine supplements. The complaint, filed ...

EXXUA is now available through Aytu RxConnect pharmacies to ensure optimal access and availabilityEXXUA has demonstrated significant improvement in depression symptoms in clinical trials involving mor ...